ABT vs LC · P/E 25, rev $44.33B vs P/E 28, $1.43B cap
Abbott Laboratories (ABT) versus LendingClub Corp (LC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
LendingClub Corp (LC) is a banks - regional company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
LC does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. LC currently screens at market cap $1.43B and trailing P/E 28.4.
Not investment advice. Open the ABT and LC stock pages for the full models.
Not investment advice.